Nighttime fasting may decrease breast cancer risk in women
the ONA take:
According to a recent study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers from the University of California, San Diego School of Medicine have found that a reduction in the amount of time spent eating and an increase in overnight fasting decreases glucose levels and may lower the risk of breast cancer among women.
In the study, participants reported eating five times per day with an average fasting of 12 hours during the nighttime. Women who reported longer fasting periods also consumed fewer calories during the day, ate fewer calories after 10 p.m, and had a fewer eating episodes.
Results showed that women who had a longer fasting duration overnight had significantly better glycemic control. In addition, researchers found that each 3 hour increase in overnight fasting was associated with a 4% lower postprandial glucose level.
The researchers note that larger studies are needed to confirm that overnight fasting improves glycemic control and reduces breast cancer risk.
An increase in overnight fasting decreases glucose levels and may lower the risk of breast cancer among women.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|